Apr 30, 2014 at 08:31 | Source: CNBC-TV18
Bharti Airtel | Indian Overseas Bank | Wockhardt | HDFC Bank | CEAT | Future Retail | MCX | Financial Technologies | Coromandel Engineering | Mahindra CIE | Welspun Corp | ING Vysya Bank | Sun Pharma | Siemens | Ranbaxy Labs | Cipla | Marico and Kotak Mahindra Bank are stocks, which are in the news today.
Apr 28, 2014 at 17:43 | Source: Moneycontrol.com
Raamdeo Agrawal of Motilal Oswal believes that the market has already priced in a Modi-led government. He, however, warns that a landslide win for BJP's Prime Ministerial Candidate Modi is not factored in.
Apr 25, 2014 at 08:27 | Source: CNBC-TV18
ICICI Bank | Axis Bank | Maruti Suzuki | UltraTech Cement | Cairn India | Biocon | Ambuja Cements | ACC | L&T Finance Holdings | M&M Financial Services | South Indian Bank | Bharti Infratel | Tata Metaliks | Granules India | HDFC Bank and Muthoot Finance are stocks, which are in the news today.
Apr 09, 2014 at 10:26 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, pharma stocks like Sun Pharma, Aurobindo Pharma, Lupin, Ranbaxy, Dr Reddys Labs, Wockhardt, Glenmark Pharma and Biocon will get astrological support.
Apr 04, 2014 at 10:24 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, pharma stocks like Ranbaxy Laboratories, Lupin, Dr Reddys Laboratories, Sun Pharmaceutical Industries, Wockhardt, Glenmark Pharma and Biocon will get astrological support.
Apr 03, 2014 at 16:34 | Source: CNBC-TV18
Rajesh Agarwal, director-research at Eastern Financiers suggest holding Torrent Pharma with a target of Rs 650.
Apr 03, 2014 at 10:29 | Source: CNBC-TV18
Anmol Ganjoo, VP-institutional equities, JM Financial says the recent spate of good news has led the market to believe that the issues face by the pharma sector may be on the mend.
Apr 03, 2014 at 10:19 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, auto stocks like Maruti Suzuki India, Mahindra and Mahindra, Ashok Leyland and Tata Motors will get astrological support.
Apr 02, 2014 at 23:14 | Source: CNBC-TV18
In yet another patent infringement battles in India, Swiss drug maker Novartis has taken Indian biotech firm Biocon to court on anti-diabetes drug. Novartis has sued Biocon in Delhi HC on patent infringement on Galvus, chemical name Vildagliptin, and the court has ruled partly in its favour reports CNBC TV18s Archana Shukla.
Mar 13, 2014 at 09:55 | Source: CNBC-TV18
Indian pharmaceutical company Sun Pharma has received an USFDA import alert for all products manufactured at its Karkhadi unit. The company manufactures API and formulations at its Karkhadi Unit.